Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Revenues, Total		$ 24,494	$ 24,223	$ 74,369	$ 71,255
Expenses:
Depreciation and amortization		7,009	7,012	20,624	20,479
Other operating expenses		7,609	7,854	22,115	23,625
Costs and Expenses, Total		16,004	16,198	46,832	48,061
Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense		8,490	8,025	27,537	23,194
Equity in income of unconsolidated LLCs		300	314	956	953
Interest expense, net		(4,793)	(4,467)	(13,920)	(12,340)
Net income		$ 3,997	$ 3,872	$ 14,573	$ 11,807
Basic earnings per share		$ 0.29	$ 0.28	$ 1.06	$ 0.86
Diluted earnings per share		$ 0.29	$ 0.28	$ 1.05	$ 0.85
Weighted average number of shares outstanding - Basic		13,807	13,790	13,799	13,784
Weighted average number of shares outstanding - Diluted		13,849	13,822	13,835	13,811
Management Service
Expenses:
Advisory fees to UHS		$ 1,386	$ 1,332	$ 4,093	$ 3,957
UHS Facilities
Revenues:
Lease revenue	[1]	8,248	8,274	25,366	24,297
Interest income on financing leases - UHS facilities		1,357	1,365	4,077	4,096
UHS Facilities | Other
Revenues:
Other revenue		242	254	682	730
Non-Related Parties
Revenues:
Lease revenue		14,342	13,926	43,188	40,955
Non-Related Parties | Other
Revenues:
Other revenue		$ 305	$ 404	$ 1,056	$ 1,177

[1] Includes bonus rental on McAllen Medical Center, a UHS acute care hospital facility of $765 and $725 for the three-month periods ended September 30, 2024 and 2023, respectively, and $2,306 and $2,219 for the nine-month periods ended September 30, 2024 and 2023, respectively.